Delcath Systems, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 2836 www.delcath.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - Apr 28th, 2025 12:30 pm
Delcath Systems to Host First Quarter 2025 Earnings Call - Apr 24th, 2025 8:01 pm
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma - Apr 9th, 2025 9:00 pm
Beta Bionics Announces Board Appointment of Gerard Michel - Mar 27th, 2025 8:45 pm
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Mar 24th, 2025 8:01 pm
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Mar 14th, 2025 8:01 pm
Earnings Beat: Delcath Systems, Inc. (NASDAQ:DCTH) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Mar 8th, 2025 1:37 pm
Here's Why We're Not Too Worried About Delcath Systems' (NASDAQ:DCTH) Cash Burn Situation - Mar 7th, 2025 10:26 am
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results - Mar 6th, 2025 1:00 pm
Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call - Feb 20th, 2025 1:30 pm
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma - Feb 14th, 2025 1:30 pm
Biotech walks a 'tightrope' amid unclear funding, regulations - Jan 31st, 2025 12:00 pm
Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Jan 28th, 2025 9:01 pm
retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week - Jan 26th, 2025 12:46 pm
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - Jan 13th, 2025 1:00 pm
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Jan 3rd, 2025 9:01 pm
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises - Dec 30th, 2024 1:00 pm
3 US Growth Companies To Watch With Up To 32% Insider Ownership - Dec 30th, 2024 11:01 am
Analysts Expect Breakeven For Delcath Systems, Inc. (NASDAQ:DCTH) Before Long - Dec 29th, 2024 1:10 pm
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - Dec 2nd, 2024 1:30 pm